Larotrectinib efficacy and safety in adult TRK fusion cancer patients.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David S. Hong, Shivaani Kummar, Anna F. Farago, Ulrik Niels Lassen, Jordan Berlin, Russell J. Schilder, Raymond S. McDermott, Jyoti D. Patel, Afshin Dowlati, Robert Charles Doebele, Daniel Shao-Weng Tan, James J. Lee, Shivani Nanda, Barrett H. Childs, Nora Ku, Alexander E. Drilon, David Michael Hyman
Institutions: The University of Texas MD Anderson Cancer Center, Stanford Cancer Institute, Stanford University, Massachusetts General Hospital, Rigshospitalet, Vanderbilt University, Thomas Jefferson University, Cancer Trials Ireland, St. Vincent's University Hospital, University of Chicago Medical Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, University of Colorado Denver, National Cancer Centre Singapore, University of Pittsburgh, University of Pittsburgh Medical Center, Bayer (United States), Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4238313832